Universal Biofactor-Releasing Scaffold Enabling in Vivo Reloading.
Tissue engineering
controlled release
growth factors
reloading
scaffolds
vascularization
Journal
Nano letters
ISSN: 1530-6992
Titre abrégé: Nano Lett
Pays: United States
ID NLM: 101088070
Informations de publication
Date de publication:
13 03 2019
13 03 2019
Historique:
pubmed:
1
3
2019
medline:
16
7
2019
entrez:
1
3
2019
Statut:
ppublish
Résumé
The supply of growth factors to engineered tissues is essential for many physiological processes. These processes include the proper organization of the cells into functioning tissues, maintenance of their viability, vasculogenesis, proliferation, and differentiation. Systems to efficiently control the release of growth factors were previously incorporated into tissue engineering scaffolds to affect cells. However, because the initial concentration of the factors in these systems is finite, their ability to provide a long-term physiological effect is limited. Here, we report on a new reloadable system in which 3D fibrous scaffolds conjugated with an anti His-tag antibody enable the retention and controlled release of any His-tag-modified proteinaceous growth factor. The scaffolds can be reloaded in vitro or in vivo with any His-tagged biomolecule at any time according to the physiological need. We show the ability of the scaffolds to release angiogenic factors in a static cell culture or under flow in a microfluidics device and effect on endothelial cells. We also demonstrate the potential of the system to be sequentially reloaded in vivo with various factors, and as a proof of concept, we provide evidence for the efficient in vivo vascularization of scaffolds after reloading with tagged VEGF.
Identifiants
pubmed: 30817160
doi: 10.1021/acs.nanolett.8b04927
pmc: PMC7100042
mid: EMS86069
doi:
Substances chimiques
Immunoconjugates
0
VEGFA protein, human
0
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1838-1843Subventions
Organisme : European Research Council
ID : 637943
Pays : International
Références
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14990-5
pubmed: 19706385
J Immunol Methods. 2015 Feb;417:86-96
pubmed: 25536073
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3287-92
pubmed: 19966309
Biofabrication. 2014 Jun;6(2):024101
pubmed: 24464690
J Control Release. 2015 Jun 10;207:7-17
pubmed: 25836592
J Control Release. 2010 Apr 2;143(1):45-52
pubmed: 19963026
J Cardiovasc Transl Res. 2014 Mar;7(2):232-41
pubmed: 24395494
Expert Opin Drug Deliv. 2012 Apr;9(4):473-92
pubmed: 22432691
J Orthop Res. 2011 Jul;29(7):1099-105
pubmed: 21246611
J Biomed Mater Res A. 2003 Jun 15;65(4):489-97
pubmed: 12761840
Nat Biotechnol. 2001 Nov;19(11):1029-34
pubmed: 11689847
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1898-1903
pubmed: 28167795
Adv Healthc Mater. 2019 Jan;8(1):e1801000
pubmed: 30398700
J Control Release. 2018 Jul 10;281:189-195
pubmed: 29782947
Nanotechnology. 2018 Apr 3;29(13):13LT01
pubmed: 29384490
Biomater Sci. 2015 May;3(5):742-52
pubmed: 26222593
Biomaterials. 2009 Apr;30(11):2122-31
pubmed: 19152972
J Control Release. 2014 Nov 28;194:316-22
pubmed: 25245775
Biotechnol Bioeng. 2014 Jun;111(6):1246-57
pubmed: 24420414
Biomaterials. 2012 Jan;33(2):494-503
pubmed: 22014943